206 results
8-K
EX-10.3
INVA
Innoviva Inc
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
Page
Article I DEFINITIONS
Article II PREPARATION AND FILING OF TAX RETURNS
Section 2.1
Theravance’s Responsibility
Section 2.2
Biopharma’s … Responsibility
Section 2.3
Agent
Section 2.4
Manner of Tax Return Preparation
Section 2.5
Tax Services
Article III LIABILITY FOR TAXES
Section 3.1
Theravance’s
8-K
EX-10.4
INVA
Innoviva Inc
5 Jun 14
Theravance, Inc. and Theravance Biopharma, Inc. Announce
12:00am
pursuant to this Agreement, the responsibility of the other Party or any of its Affiliates. Any such request for reimbursement must be made not later … than the first anniversary of the Distribution Date.
(d) ParentCo shall retain responsibility for all employee-related regulatory filings for reporting
8-K
EX-10.1
INVA
Innoviva Inc
6 Jan 12
Entry into a Material Definitive Agreement
12:00am
that are the responsibility of ASTELLAS under the Parties’ “Safety Data Exchange Agreement Pertaining to Telavancin” dated October 1, 2008 (“SDEA”), upon … for such ASTELLAS-Labeled Licensed Product rebate and chargeback claims that are THERAVANCE’s financial responsibility.
6. Upon the Parties
S-3ASR
EX-10.1
zsycbx
30 Jan 06
Automatic shelf registration
12:00am
S-3ASR
EX-5.2
2hmbtlrtdu20
15 Jan 08
Automatic shelf registration
12:00am
S-3ASR
EX-5.2
5916xb09
16 Jan 13
Automatic shelf registration
12:00am
S-3ASR
EX-5.1
ftnemqhsu k39y
15 Jan 08
Automatic shelf registration
12:00am